enteric coated daily low dose asa 81 mg tablet (delayed-release)
vita health products inc - acetylsalicylic acid - tablet (delayed-release) - 81mg - acetylsalicylic acid 81mg - salicylates
asa 81 mg tablet (delayed-release)
vita health products inc - acetylsalicylic acid - tablet (delayed-release) - 81mg - acetylsalicylic acid 81mg - salicylates
coated daily low dose asa 81 mg tablet (delayed-release)
apotex inc - acetylsalicylic acid - tablet (delayed-release) - 81mg - acetylsalicylic acid 81mg - salicylates
rivasa 81 mg ec tablet (delayed-release)
laboratoire riva inc. - acetylsalicylic acid - tablet (delayed-release) - 81mg - acetylsalicylic acid 81mg - salicylates
jamp-asa 81mg ec tablet (enteric-coated)
vita health products inc - acetylsalicylic acid - tablet (enteric-coated) - 81mg - acetylsalicylic acid 81mg - salicylates
asa 81 mg tablet (delayed-release)
laboratoires trianon inc. - acetylsalicylic acid - tablet (delayed-release) - 81mg - acetylsalicylic acid 81mg - salicylates
apo-asa ld tablet (delayed-release)
apotex inc - acetylsalicylic acid - tablet (delayed-release) - 81mg - acetylsalicylic acid 81mg - salicylates
ambisome
gilead sciences pty ltd - amphotericin b -
ambisome
gilead sciences (nz) - amphotericin b 50mg - powder for injection - 50 mg - active: amphotericin b 50mg excipient: cholesterol hydrochloric acid alpha-tocopherol distearoylphosphatidylglycerol phosphatidylcholines, soya, hydrogenated phosphatidylglycerols as sodium salt sodium hydroxide sodium succinate sucrose - ambisome is indicated for: · prophylaxis in liver transplant patients at risk of systemic candida, aspergillus and cryptococcus infections, and for · the treatment of systemic fungal infections caused by organisms susceptible to amphotericin b. ambisome is indicated for empirical treatment of presumed fungal infections in febrile neutropaenic patients whose fever has failed to respond to broad spectrum antibiotic treatment. ambisome is indicated for the treatment of visceral leishmaniasis. clinical studies of efficacy in visceral leishmaniasis are limited to leishmania infantum.
cardoxin forte
rafa laboratories ltd - dipyridamole - tablets - dipyridamole 75 mg - dipyridamole - dipyridamole - as an adjunct to oral anticoagulants for prophylaxis of thromboembolism associated with prosthetic heart valves. reduction of proteinuria in the nephrotis syndrome. treatment of membranoproliferative glomerulonephritis. prevention of pre-eclampsia in the final trimester of pregnancy. prevention of transplant artery stenosis. prevention of post-operative thromboembolic complications of coronary artery surgery. in combination with acetylsalicylic acid in cases of recurrent deep vein thrombosis resistant to oral anticoagulants. prevention of thrombogenic manifestations. as an alternative to exercise stress in thallium myocardial imaging particularly in patients unable to exercise or in those for whom exercise may be contraindicated.